In Russia, clinical use of a colon cancer vaccine called Oncopt has begun. This was announced by the deputy head of the FMBA of Russia Igor Borisevich.
"A vaccine based on neo-antigens of cancer cells in a specific patient has been developed, registered and is now being used clinically," TASS quotes Borisevich.